Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Nadolol × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Cirrhosis 1 Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 19 Capecitabine 16 Fluorouracil 14 Bevacizumab 13 Esomeprazole 11 Sorafenib 9 Irinotecan 8 Propofol 7 Leucovorin 7 Bismuth 7 Radiofrequency Ablation 6 Morphine 6 Folfox protocol 6 Amoxicillin 6 lenvatinib 5 gadolinium ethoxybenzyl DTPA 5 Tetracycline 5 Sevoflurane 5 S 1 (combination) 5 sodium glycididazole 4 fish oil triglycerides 4 ferric carboxymaltose 4 Ribavirin 4 Hepatectomy 4 HMPL-013 4 Gemcitabine 4 Furazolidone 4 Control Groups 4 Cetuximab 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00567216 2010-06-08

GVO-nadolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡